Aeglea Biotherapeutics
NASDAQ: SYREAustin, US · Founded 2015 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
CN
Charles N. YorkExecutive Officer
DG
David G. LoweExecutive Officer, Director
HS
Henry SkinnerDirector
GG
George GeorgiouDirector
AS
Armen ShanafeltDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$180MraisedDec 2023 · 30 investors · BiotechnologyRule 506(b)
▶$180MraisedDec 2023 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cameron TurtleExecutive Officer, Director
- Tomas KiselakDirector
- Scott BurrowsExecutive Officer
- Laurie StelzerDirector
- Russell J. CoxDirector
- Peter HarwinDirector
- Alison LawtonDirector
- Michael HendersonDirector
- Heidy King-JonesExecutive Officer
- Jeffrey W. AlbersDirector
- Offering amount
- $180M
- Amount sold
- $180M
- Finders' fees
- $10.8M
- Placement agents
- Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated, Guggenheim Securities, LLC, LifeSci Capital LLC, Jefferies LLC
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$210MraisedJul 2023 · 41 investors · BiotechnologyRule 506(b)
▶$210MraisedJul 2023 · 41 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tomas KiselakDirector
- Peter HarwinDirector
- Michael HendersonDirector
- Cameron TurtleExecutive Officer
- Jonathan AlspaughExecutive Officer
- Alison LawtonDirector
- Ivana Magovcevic-LiebischDirector
- Hunter C, SmithDirector
- Russell J. CoxDirector
- Cortney CaudillExecutive Officer
- Offering amount
- $210M
- Amount sold
- $210M
- Finders' fees
- $12.6M
- Placement agents
- Cowen and Company, LLC, Guggenheim Securities, LLC, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44MraisedMar 2015 · 54 investors · BiotechnologyRule 506(b)
▶$44MraisedMar 2015 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles N. YorkExecutive Officer
- David G. LoweExecutive Officer, Director
- Henry SkinnerDirector
- George GeorgiouDirector
- Armen ShanafeltDirector
- Offering amount
- $44M
- Amount sold
- $44M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.